AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25410205
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of Peru-15 pCTB vaccine
Trial: 30169323
Drug: Late parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late parenteral nutrition
Trial: 18955454
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m² every 3 weeks plus lapatinib 1,500 mg/d
Trial: 10758783
Drug: Methylprednisolon‐ratiopharm 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolon‐ratiopharm 8 mg tablets (test preparation)
Trial: 10758783
Drug: Reference preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference preparation 8 mg tablets (control)
Trial: 30260990
Drug: gemfibrozil (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemfibrozil (1200 mg/day)
Trial: 7856526
Drug: simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: simvastatin (20 mg/day)
Trial: 3976757
Drug: 17 alpha-hydroxyprogesterone
RxNorm normalized name: 17 alpha-hydroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 alpha-hydroxyprogesterone caproate, 250 mg by intramuscular injection once a week
Trial: 22622851
Drug: Vaginal combination
RxNorm normalized name: CVS Miconazole 3 Vaginal Combination Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal combination therapy including 500 mg metronidazole and 100 mg miconazole nitrate two times a day for 7 days
Trial: 22622851
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no preoperative vaginal therapy)
Trial: 10619824
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (500 microg twice daily)
Trial: 6712851
Drug: Naloxone 0.006
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone 0.006 mg kg‐1 5 min before induction of anaesthesia
Trial: 27836715
Drug: Improvisation Theater
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Improvisation Theater (IT) program, 60 min sessions weekly for 12 weeks
Trial: 26581787
Drug: Resistance training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance training (once- or twice-weekly)
Trial: 26581787
Drug: Balance-and-toning (twice-weekly)
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balance-and-toning (twice-weekly)
Trial: 23886521
Drug: Lidocaine 1mg/mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1mg/mL
Trial: 23579103
Drug: Lidocaine 10mg/mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 10mg/mL
Trial: 19382010
Drug: Paroxetine controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine controlled release (CR) 12.5-62.5 mg/day
Trial: 17005075
Drug: Quyu Xiaoban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quyu Xiaoban Capsule (QYXBC) for 10 months
Trial: 12725259
Drug: Heparin in
RxNorm normalized name: heparin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin in addition to antisnake venom (ASV)
Trial: 7909642
Drug: Prehydration with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prehydration with balanced electrolyte solution
Trial: 26868123
Drug: 4000 IU
RxNorm normalized name: Cholecalciferol 4000 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4000 IU D3 daily for 6 months
Trial: 26868123
Drug: 600 IU
RxNorm normalized name: Vitamin E 4600 IU/5 ML Oral Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 IU D3 daily for 6 months
Trial: 25775024
Drug: CHOP chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHOP chemotherapy in combination with Ofatumumab (CHOP-O)
Trial: 25775024
Drug: Ofatumumab maintenance
RxNorm normalized name: Ofatumumab
DrugBank: Ofatumumab (DB06650)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ofatumumab maintenance therapy
Trial: 23090424
Drug: Intermittent drain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent drain clamping with injection of diluted epinephrine solution (Group I)
Trial: 23090424
Drug: Nonclamping without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonclamping without injection of diluted epinephrine solution (Group II)
Trial: 23488876
Drug: 0.5 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg alcohol
Trial: 11104118
Drug: 1.0 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g/kg alcohol
Trial: 1586604
Drug: Chemotherapy (cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (cyclophosphamide 1,000 mg m‐2 i.v., doxorubicin 50 mg m‐2 i.v., vincristine 1.4 mg m‐2 i.v., and prednisolone 40 mg orally for 5 days, given 3 weekly for four cycles) + Radiotherapy (CHOP + RT)
Trial: 1586604
Drug: Chemotherapy (CHOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (CHOP + RT)
Trial: 2872569
Drug: L-363,586 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-363,586 (10 micrograms/hr)
Trial: 27570088
Drug: Intravenous ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ferric carboxymaltose (1000 mg single dose)
Trial: 24170101
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen treatment for 3 weeks
Trial: 22904179
Drug: GH 2
RxNorm normalized name: ColdCough 2mg-7.5mg-15mg/5ml Syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH 2 mg/m(2) · d during puberty
Trial: 21275161
Drug: Three-step acupuncture
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-step acupuncture (TSA) combined with small dosage antipsychotic
Trial: 21275161
Drug: Full-dose antipsychotic
RxNorm normalized name: Rho(D) immune globulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose antipsychotic
Trial: 3846198
Drug: Single-dose treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose treatment with amoxicillin (3.0 g single dose)
Trial: 3846198
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with amoxicillin (250 mg three times daily for ten days)
Trial: 31888504
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of remifentanil (group R)
Trial: 28213783
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (doxorubicin, 5-fluorouracil/mitomycin, or epirubicin)
Trial: 28213783
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (paclitaxel)
Trial: 11132761
Drug: IV vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV vitamin C 500 mg administered three times a week for three months
Trial: 11132761
Drug: IV vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV vitamin C 500 mg administered three times a week for the second three months
Trial: 9060568
Drug: Sucralfate solution
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate solution
Trial: 8453970
Drug: Amoxycillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (3 g)
Trial: 8437256
Drug: Ofloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (400 mg)
Trial: 30562268
Drug: i.v. morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. morphine (0.09-mg/kg total)
Trial: 30562268
Drug: i.v. naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. naloxone (12-mg total)
Trial: 29717840
Drug: TRUSC-guided administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TRUSC-guided administration of traditional Chinese medicine, qd for 7 days before TURP
Trial: 29717840
Drug: TRUSC-guided administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TRUSC-guided administration of traditional Chinese medicine
Trial: 12825062
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg diazepam and 0.015 mg/kg atropine sulfate
Trial: 6661346
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg AQ‐A 39
Trial: 6661346
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg AQ‐A 39
Trial: 26655084
Drug: NS11821 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NS11821 (10 mg, 30 mg, 75 mg, 150 mg, 300 mg, 600 mg)
Trial: 20814315
Drug: Low-dose risperidone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose risperidone plus low-dose haloperidol (2 mg/d risperidone + 2 mg/d haloperidol)
Trial: 20814315
Drug: Risperidone monotherapy
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone monotherapy (4 mg/d risperidone)
Trial: 17905486
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine (VAQTA) administered at 6 and 12 months of age
Trial: 17905486
Drug: Hexavalent vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexavalent vaccine (HEXAVAC) administered at 2, 4, 6, and 12 months of age
Trial: 15677625
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy plus ovarian suppression (either radiation-induced ovarian ablation or triptorelin for 3 years)
Trial: 15677625
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy alone (control arm)
Trial: 15677625
Drug: Ovarian suppression
RxNorm normalized name: Buckley's Cough Suppressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ovarian suppression in patients <40 years of age with estrogen receptor-positive tumors
Trial: 8624122
Drug: Besipirdine 5
RxNorm normalized name: Nerispirdine
DrugBank: Nerispirdine (DB12714)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Besipirdine 5 mg BID
Trial: 8624122
Drug: Besipirdine 20
RxNorm normalized name: Nerispirdine
DrugBank: Nerispirdine (DB12714)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Besipirdine 20 mg BID
Trial: 1923396
Drug: Topical medication
RxNorm normalized name: Procto-Med Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical medication containing tannic acid
Trial: 30721296
Drug: EEG-guided anesthetic
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EEG-guided anesthetic administration
Trial: 26715763
Drug: Intradialytic resistance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradialytic resistance training using resistance elastic bands in a seated position during the first hour of haemodialysis treatment for 12, 24 or 36 weeks
Trial: 19527468
Drug: Polaprezinc (34
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polaprezinc (34 mg/day)
Trial: 3519285
Drug: 6 courses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 courses of a 'CMF like' chemotherapy
Trial: 3146465
Drug: Sodium fusidate
RxNorm normalized name: Sodium fusidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium fusidate ointment
Trial: 25935145
Drug: Intravenous delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous delivery of flurbiprofen axetil, pentazocine and palonosetron via intravenous pump
Trial: 22000847
Drug: Oral fluconazole
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral fluconazole 150 mg single dose
Trial: 22000847
Drug: Intra-vaginal clotrimazole
RxNorm normalized name: clotrimazole Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-vaginal clotrimazole 200 mg per day for six days
Trial: 18374245
Drug: Environmental factors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Environmental factors (e.g., fewer culs-de-sac)
Trial: 12839615
Drug: Betamethasone dipropionate
RxNorm normalized name: Betamethasone Dipropionate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone dipropionate lotion (BDL)
Trial: 10607678
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy with autologous stem cell support (NMSG #5/94)
Trial: 9252721
Drug: FEMP+PSK (5-fluorouracil,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FEMP+PSK (5-fluorouracil, cyclophosphamide, mitomycin C, predonisolone + 3.0 g of PSK)
Trial: 9252721
Drug: NA (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NA (no adjuvant therapy)
Trial: 1556679
Drug: Sodium Meclofenamate
RxNorm normalized name: Meclofenamate Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium Meclofenamate (Meclomen) 100 mg po tid
Trial: 1556679
Drug: Diclofenac Sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac Sodium (Voltaren) 25 mg po tid
Trial: 30342554
Drug: Dexamethasone (DXM)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DXM) therapy, 16 mg per day (8 mg twice daily, days 1 to 4), halved every 3 days until 0.5 mg on day 19, stopped on day 20.
Trial: 30342554
Drug: Dexamethasone (DXM)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DXM) therapy
Trial: 27232899
Drug: Hydrogen peroxide
RxNorm normalized name: Hydrogen Peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrogen peroxide solution (H2O2) for 3 months
Trial: 27232899
Drug: Biguanide‐preserved multipurpose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biguanide‐preserved multipurpose solution (BMPS) for 3 months
Trial: 27232899
Drug: Hydrogen peroxide
RxNorm normalized name: Hydrogen Peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrogen peroxide solution (H2O2)
Trial: 24405579
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group received access to a 'Rolling Store', nutrition education, and physical activity.
Trial: 3156621
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy
Trial: 12358368
Drug: Gentamicin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin (5 mg/kg)
Trial: 12358368
Drug: Cefuroxime (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime (1.5 g)
Trial: 3516257
Drug: Cetiedil at
RxNorm normalized name: cetiedil
DrugBank: Cetiedil (DB13753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetiedil at 0.4 mg/kg body weight
Trial: 29432967
Drug: Timothy grass
RxNorm normalized name: Timothy grass
DrugBank: Phleum pratense top (DB14179)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timothy grass SLIT‐T taken once daily for 4 months
Trial: 29432967
Drug: Placebo taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo taken once daily for 4 months
Trial: 29052340
Drug: Non-nucleoside reverse
RxNorm normalized name: Non-nucleoside reverse transcriptase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-nucleoside reverse transcriptase inhibitor (NNRTI) based ART
Trial: 24050970
Drug: Eperisone hydrochloride
RxNorm normalized name: Eperisone hydrochloride
DrugBank: Eperisone (DB08992)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eperisone hydrochloride (3 doses of 50 mg each)
Trial: 24050970
Drug: Aceclofenac (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aceclofenac (2 doses of 100 mg each)
Trial: 24050970
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of eperisone hydrochloride and aceclofenac
Trial: 20091161
Drug: Ticagrelor 100-400
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor 100-400 mg
Trial: 12802748
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone (1 g daily for 7 days; n=87)
Trial: 12802748
Drug: Intravenous sodium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sodium penicillin G (1.5 million U every 6 h for 7 days; n=86)
Trial: 12802748
Drug: Sodium penicillin
RxNorm normalized name: Penicillin G Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium penicillin G
Trial: 10566924
Drug: 75 microg
RxNorm normalized name: Norgestrel 75 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 microg oral clonidine
Trial: 10566924
Drug: 150 microg
RxNorm normalized name: Norgestrel 150 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 microg oral clonidine
Trial: 6723225
Drug: Heparin sodium
RxNorm normalized name: Heparin Sodium
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin sodium
Trial: 21248199
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein and high PRAL diet (HPHP; total protein: 118 g/d; PRAL: 33 mEq/d)
Trial: 21248199
Drug: Low protein
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low protein and low PRAL diet (LPLP; total protein: 61 g/d; PRAL: ‐48 mEq/d)
Trial: 9745413
Drug: 0.3 mg/kg.week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg.week recombinant human GH
Trial: 8751029
Drug: Spirapril 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 1.5 mg
Trial: 9493699
Drug: Spirapril 3
RxNorm normalized name: spirapril 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 3 mg
Trial: 9493699
Drug: Spirapril 6
RxNorm normalized name: spirapril 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril 6 mg
Trial: 8751029
Drug: Enalapril 5/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5/10 mg
Trial: 12053028
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of oral sildenafil citrate combined with self‐manual and visual sexual stimulation
Trial: 12053028
Drug: Combined intracavernosal
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined intracavernosal injection of 60 mg of papaverine and sexual stimulation (CIS)
Trial: 10444027
Drug: SC602 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC602 vaccine
Trial: 7916183
Drug: RP 56976
RxNorm normalized name: RP-72
DrugBank: RP-72 (DB17156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RP 56976 (docetaxel) at 60 mg/m2
Trial: 7916183
Drug: RP 56976
RxNorm normalized name: RP-72
DrugBank: RP-72 (DB17156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RP 56976 (docetaxel) at 70-90 mg/m2
Trial: 2666293
Drug: Famotidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine (1 40 mg tablet at night)
Trial: 2666293
Drug: Ranitidine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (2 150 mg tablets at night)
Trial: 1234507
Drug: Intramuscular salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular salbutamol (8 mug/kg)
Trial: 1234507
Drug: Intramuscular salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular salbutamol (4 mug/kg)
Trial: 1234507
Drug: Intramuscular salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular salbutamol (12 mug/kg)
Trial: 28343658
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care treatment (control group)
Trial: 17054107
Drug: Lanreotide Autogel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanreotide Autogel (Lan ATG) 120 mg every 6 weeks
Trial: 17054107
Drug: Lanreotide microparticles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanreotide microparticles (Lan MP) 60 mg every 3 weeks
Trial: 14510743
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (1 g)
Trial: 21715702
Drug: Bromocriptine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (2.5 mg)
Trial: 9024246
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bromocriptine, cyproheptadine, and valproic acid
Trial: 3056447
Drug: Capozide (captopril,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capozide (captopril, 25 mg with 15 mg hydrochlorothiazide)